Chetak Raghavana, Manasa K. S.*b, Laigin Sebastianb

EJECTION FRACTION-GUIDED PHARMACOTHERAPY IN CORONARY ARTERY DISEASE: A CROSS-SECTIONAL STUDY OF DIURETIC, RENIN–ANGIOTENSIN SYSTEM INHIBITOR, AND SACUBITRIL/VALSARTAN (ARNI) PRESCRIBING PATTERNS

Background: Left ventricular (LV) systolic function, quantified by ejection fraction (EF), is a key determinant of pharmacotherapy selection in coronary artery disease (CAD), guiding the use of diuretics, renin–angiotensin system (RAS) inhibitors, and, in patients with markedly r...

EJECTION FRACTION-GUIDED PHARMACOTHERAPY IN CORONARY ARTERY DISEASE: A CROSS-SECTIONAL STUDY OF DIURETIC, RENIN–ANGIOTENSIN SYSTEM INHIBITOR, AND SACUBITRIL/VALSARTAN (ARNI) PRESCRIBING PATTERNS

Background: Left ventricular (LV) systolic function, quantified by ejection fraction (EF), is a key determinant of pharmacotherapy selection in coronary artery disease (CAD), guiding the use of diuretics, renin–angiotensin system (RAS) inhibitors, and, in patients with markedly r...